In a cross-sectional analysis of data from NHANES, uninsured individuals with CKD were less likely to have controlled hypertension or to receive an angiotensin-converting enzyme inhibitor (ACEi) than those with insurance [21, 25]. This evidence concerns the gene ACE and Hypertension.